Biopharmaceuticals Market Research Reports & Industry Analysis
Biopharmaceuticals are a class of drugs produced using living organisms or their cellular components to treat various medical conditions. By providing highly targeted and sophisticated therapeutic options, biopharmaceuticals have revolutionized the field of medicine. If you are in search of comprehensive and objective data on this fast-growing market, you have come to the right place. MarketResearch.com offers hundreds of biopharmaceuticals industry reports published by leading research firms.
New Biopharmaceuticals Market Research
- Use our reports to explore diverse markets in the biopharmaceuticals industry, from biosimilars to enzymes to antibodies.
- Gain invaluable insights, including biopharmaceuticals market size, growth, and industry trends.
- Get up to speed on the latest technological breakthroughs, opportunities, and market-entry strategies.
Proven Expertise in the Field of Market Research
With a track record spanning more than two decades, MarketResearch.com is a trusted source for market research. We serve top-tier investment banks, management consulting firms, and Fortune 500 multinational corporations. Our dedicated research specialists are here to provide recommendations and guidance throughout your research process. Improve your knowledge and enhance your strategies with biopharmaceutical market research from MarketResearch.com today.
Biopharmaceuticals Industry Research & Market Reports
-
Global Biopharmaceutical Tubing Market - 2023-2030
... growing at a CAGR of 8.3% during the forecast period 2024–2031. The biopharmaceutical tubing market trend shows rising demand for these products owing to the rapid growth of single-use systems (SUS) in the biopharmaceutical industry, ... Read More
-
Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Region 2025-2033
... 2025-2033. The increasing outsourcing trends, rising demand for medications and medical devices, stringent regulatory compliance, product diversification and cost-effectiveness, significant technological advancements, and increasing environmental considerations are some of the major factors propelling the market. ... Read More
-
Global Biosimilars Market 2025-2029
... analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, ... Read More
-
Global Biosimilars Market – Products, Applications and Regulations
... such as yeast, bacteria, or animal cells and are complex and sensitive to changes in manufacturing, in contrast to generic drugs, which are precise chemical replicas of small-molecule drugs. Biosimilars include various types of products, ... Read More
-
Biopharmaceuticals – A Global Market Overview
... complex molecules, including proteins, nucleic acids, and vaccines, in contrast to traditional small-molecule drugs. Biopharmaceutical products are developed to address chronic, complex, and rare illnesses, providing targeted treatments that conventional drugs often lack. They are ... Read More
-
Bioburden Testing
... CAGR of 11.3% over the analysis period 2024-2030. Bioburden Testing Consumables, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Electronic Laboratory Notebooks (ELNs)
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Cross-disciplinary ELNs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$801.2 Million by the ... Read More
-
Biopharmaceutical Bioseparation Systems
... at a CAGR of 10.9% over the analysis period 2024-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$15.8 Billion by the end of ... Read More
-
Single-Use Bioprocessing
... CAGR of 20.8% over the analysis period 2024-2030. Single-Use Media Bags & Containers, one of the segments analyzed in the report, is expected to record a 22.6% CAGR and reach US$29.9 Billion by the end ... Read More
-
Autoimmune Disease Therapeutics
... at a CAGR of 3.8% over the analysis period 2024-2030. Anti-inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$183.0 Billion by the end of ... Read More
-
PEGylated Proteins
... CAGR of 9.1% over the analysis period 2024-2030. PEGylated Proteins Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$1.3 Billion by the end of the ... Read More
-
Bioreactors and Fermenters
... at a CAGR of 10.9% over the analysis period 2024-2030. Single-use Bioreactors, one of the segments analyzed in the report, is expected to record a 12.8% CAGR and reach US$3.2 Billion by the end of ... Read More
-
Biologics
... 8.2% over the analysis period 2024-2030. Recombinant Therapeutic Proteins, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$271.3 Billion by the end of the analysis period. ... Read More
-
Biopharmaceutical Logistics
... CAGR of 4.8% over the analysis period 2024-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$37.9 Billion by the end of the ... Read More
-
Spine Biologics
... CAGR of 4.4% over the analysis period 2024-2030. Spinal Allografts, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.4 Billion by the end of the analysis ... Read More
-
Biopharmaceutical Fermentation Systems
... at a CAGR of 4.5% over the analysis period 2024-2030. Upstream Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.5 Billion by the end of ... Read More
-
Biopharmaceuticals Manufacturing Consumables Testing
... 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Compendial & Multi Compendial Laboratory Testing, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach ... Read More
-
Adalimumab, Infliximab, Etanercept And Trastuzumab Biosimilars Global Market Opportunities And Strategies To 2033
... Application: Crohn’s Disease; Psoriatic Arthritis; Rheumatoid Arthritis; Ulcerative Colitis; Ankylosing Spondylitis; Plaque Psoriasis4) By Trastuzumab Biosimilars (By Application): Adjuvant Breast Cancer; Metastatic Breast Cancer; Metastatic Gastric CancerCovering: Amgen Inc.; Samsung Biologics Co., Ltd.; Biocon Limited; ... Read More
-
Global Biologics and Biosimilars Market Growth (Status and Outlook) 2025-2031
... expected to grow at a CAGR of 9.0% from 2025 to 2031. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth ... Read More
-
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2025
... used for the treatment of various diseases, including cancer, autoimmune disorders, and genetic diseases. Biologics are often highly complex and require specialized manufacturing techniques to ensure their safety, efficacy, and consistency. Biosimilars, on the other ... Read More
-
Global Aflibercept Biosimilars Competitive Landscape Professional Research Report 2025
... used primarily to treat various retinal diseases, including age-related macular degeneration (AMD) and diabetic retinopathy. These biosimilars undergo rigorous testing to demonstrate their equivalence in terms of safety, efficacy, and quality to the reference product, ... Read More
-
Global Erythropoietin Drugs Market - 2025-2032
... forecast period 2025-2032. Erythropoietin drugs are synthetic forms of the naturally occurring hormone erythropoietin (EPO), which is primarily produced by the kidneys. EPO plays a crucial role in regulating red blood cell production in the ... Read More
-
Anti-Obesity Drugs Market by Type of Molecule (Biologics and Small Molecules), Active Compound Used (Tirzepatide, Semaglutide, Retatrutide, Survodutide, Cagrilintide and Semaglutide, Orforglipron, Liraglutide and Other Active Compounds), Mechanism of Action (GLP-1 Agonist / GIP Agonist, GLP-1 Agonist / GCGR Agonist, GLP-1 Agonist, GLP-1 Agonist / Amylin Analogue, GLP-1 / GCGR / GIP Agonist and Other Mechanisms of Action), Type of Agonist (Single-Agonist, Dual-Agonist and Tri-Agonist), Action Pathway (Centrally Acting, Peripherally Acting and Centrally Acting, and Peripherally Acting), Route of Administration (Oral and Parenteral), Geographical Regions (North America, Europe, Asia-Pacific and Latin America), Sales Forecast and Key Players: Industry Trends and Global Forecasts, till 2035
... CAGR of 21. 1% during the forecast period, till 2035. The opportunity for anti-obesity drugs market has been distributed across the following segments: Type of Molecule Biologics Small Molecules Active Compound Used Tirzepatide Semaglutide Retatrutide ... Read More
-
Global Biopharmaceutical Contract Manufacturing Market - Focused Insights 2024-2029
... of the leading CMO invested over $1 billion investment in biomanufacturing in France to enhance medicine production capabilities in France. In 2023, GTP Bioways opened two new biopharmaceutical production facilities in France. In 2024, Lonza ... Read More
-
Biopharmaceutical CMO Global Market Report 2025
... Inc.; Thermo Fisher Scientific Inc.; Samsung Biologics; WuXi AppTec Biopharmaceutical CMO Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the ... Read More
Research Assistance
